Celyad Sa otc ( ($CLYYF) ) has released its Q4 earnings. Here is a breakdown of the information Celyad Sa otc presented to its investors. Celyad ...

The GI Cancers Symposium revealed new therapies for specific cancer subsets and progress in chimeric antigen receptor T-cell ...

The following is a summary of “BCMA CAR-T therapy as salvage therapy in patients with plasmablastic myeloma,” published in ...

Several studies have been conducted, but questions remain about where such therapies will fit into multiple myeloma treatment ...

If preclinical findings were translated into clinic, they could shorten CAR-T generation lead time to one day.

Munich news, health insurance, technology, jobs and other topics for expatriates. The Eye Newspapers covers daily news and offers services for foreigners.

Recent innovations include engineering CAR T-cells to overcome the immunosuppressive tumour microenvironment and enhancing ...

Researchers sought to determine whether patients with T-ALL would be responsive to salvage therapy with homoharringtonine, cytarabine, and aclarubicin.

Imagine a super-charged immune cell that can launch a focused attack on stubborn solid tumors - a smart fighter that destroys cancer cells for days without tiring.

Researchers with City of Hope and MSK have created a tool that uses machine learning to assess a non-Hodgkin lymphoma (NHL) ...

Groundbreaking cancer treatment is taking place at Albany Medical Center.New York Oncology Hematology offering CAR-T therapy, ...